Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Endocyte (ECYT)

Add to Watchlists
Create an Alert
19.29 -0.64  -3.21% NASDAQ Apr 23, 3:35PM BATS Real time Currency in USD
View Full Chart
ECYT Price Chart
View All Events

ECYT Events

Date Type Description
Feb 24 Misc Endocyte, Inc. Q4 2013 Earnings Conference Call
Feb 24 Earnings Endocyte, Inc. Q4 2013 Earnings Results. Estimate: -0.13.
Nov 05 Misc Endocyte Announces Third Quarter 2013 Earnings Conference Call
Nov 05 Earnings Q3 2013 Earnings. Estimate: -0.19.
Aug 01 Misc Endocyte Announces Second Quarter 2013 Earnings Conference Call
Aug 01 Earnings Endocyte Announces Second Quarter 2013 Earnings Release. Estimate: -0.08.
Jun 19 Misc AGM Event for Endocyte Inc
May 02 Misc Endocyte Announces First Quarter 2013 Earnings Conference Call
May 02 Earnings Endocyte Announces First Quarter 2013 Earnings. Estimate: -0.05.
View All Performance Charts

ECYT Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Endocyte is up 37.79% over the last year vs S&P 500 Total Return up 22.61%, Actelion up 71.93%, and Biogen Idec up 41.32%.

Get Quote for

Portfolio Strategies Featuring ECYT

Did Endocyte make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ECYT Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Indiana
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Endocyte, Inc. is a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ECYT 19.29 -0.64 -3.21% 697.92M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.